INSIGHTS ON CLINICAL TRIAL DESIGN
-
FDA Draft Guidance On Diversity Action Plan Requirements
Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.
-
Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)
The benefits are clear: CRM accelerates dose finding, reduces patient exposure to unsafe doses, and improves trial efficiency.
-
How AI Is Reshaping Trial Design, Execution, And Disclosure
AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
-
The Real Payoff Of Reusable IRT/RTSM System Design
By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.
-
How AI Can Accelerate Clinical Trial And Registry Builds6/29/2026
AI tools speed study design — from protocol creation to validation and analysis — by automating complex tasks and generating intelligent data while preserving control, accuracy, and flexibility.
-
Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial?5/28/2026
Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.
-
Eligibility Criteria For Successful Retinal Study Delivery1/14/2026
Clear eligibility criteria drive retinal trial success. Explore how strategic design improves recruitment, safeguards data integrity, and meets compliance for studies on complex ocular conditions.
-
Powering Complex Personalized Medicine Oncology Trial2/25/2026
Managing custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.
-
Precision Feasibility And RWD Can Boost Participant Recruitment11/17/2025
Discover how integrating independent, holistic data with precision feasibility strategies can transform site enablement and patient recruitment to unlock new levels of trial success.
CLINICAL TRIAL DESIGN SOLUTIONS
-
By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.
-
Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.
View the complete resource library.
Contact an Altasciences expert to learn more about their comprehensive clinical solution.
-
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
-
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC ServicesFast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
-
Develop effective, data-driven Diversity Action Plans tailored to your specific clinical needs with the help of an expert consulting and analytics team.